HCA Healthcare (HCA) Expected to Announce Quarterly Earnings on Friday

HCA Healthcare (NYSE:HCA) will likely be issuing its Q2 2026 results before the market opens on Friday, July 24th. Analysts expect HCA Healthcare to post earnings of $7.52 per share and revenue of $19.6833 billion for the quarter. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, July 24, 2026 at 10:00 AM ET.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period in the previous year, the business posted $6.45 EPS. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. On average, analysts expect HCA Healthcare to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

HCA Healthcare Trading Up 0.7%

Shares of HCA Healthcare stock opened at $373.14 on Wednesday. The company has a fifty day simple moving average of $389.99 and a 200-day simple moving average of $455.55. HCA Healthcare has a 12-month low of $330.00 and a 12-month high of $556.52. The stock has a market cap of $82.78 billion, a price-to-earnings ratio of 12.83, a PEG ratio of 1.23 and a beta of 1.12.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were given a dividend of $0.78 per share. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Viking Global Investors LP increased its holdings in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after acquiring an additional 690,773 shares in the last quarter. Zurich Insurance Group Ltd FI grew its position in shares of HCA Healthcare by 3,755.9% in the third quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock valued at $115,036,000 after purchasing an additional 262,912 shares during the last quarter. AQR Capital Management LLC raised its position in shares of HCA Healthcare by 83.3% during the 3rd quarter. AQR Capital Management LLC now owns 399,197 shares of the company’s stock worth $169,951,000 after purchasing an additional 181,464 shares during the last quarter. Corient Private Wealth LLC grew its holdings in HCA Healthcare by 421.4% during the 4th quarter. Corient Private Wealth LLC now owns 219,276 shares of the company’s stock valued at $102,371,000 after buying an additional 177,223 shares during the last quarter. Finally, Abdiel Capital Advisors LP raised its holdings in shares of HCA Healthcare by 35.5% in the second quarter. Abdiel Capital Advisors LP now owns 646,222 shares of the company’s stock worth $247,568,000 after acquiring an additional 169,201 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages recently issued reports on HCA. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. JPMorgan Chase & Co. reduced their price objective on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. TD Cowen lowered their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Barclays decreased their price target on shares of HCA Healthcare from $427.00 to $402.00 and set an “equal weight” rating for the company in a research note on Thursday, July 16th. Finally, KeyCorp dropped their price objective on shares of HCA Healthcare from $510.00 to $475.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 14th. Fourteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $483.45.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA continues to grow its footprint, including updates on the Long Point ER project and other facility investments, which signals ongoing network expansion. Think big: HCA rep. updates Rotary on Long Pt. ER and other projects
• Positive Sentiment: Operational hiring and promotions, including new resident physicians at HCA Florida Lake Monroe Hospital and leadership additions at HCA Florida and HCA Houston Healthcare Kingwood, may support staffing and service capacity. HCA Florida Lake Monroe Hospital welcomes 29 new resident physicians HCA Florida promotes CEO of 2 hospitals Arabinda Pani joins HCA Houston Healthcare Kingwood as CMO
• Neutral Sentiment: Additional ER expansion plans, such as the Scott’s Walk ER site search, reinforce HCA’s continued capital deployment but are unlikely to move the stock on their own. HCA readies Scott’s Walk ER, eyes location on site of closed Red Lobster in eastern Henrico
• Negative Sentiment: Multiple law firms have launched investigations into HCA after the company’s recent disappointing preliminary results, increasing legal and headline risk for investors. HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc. on Behalf of HCA Stockholders and Encourages Investors to Contact the Firm INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA NYSE: HCA Investigation: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm HCA INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud NYSE: HCA Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm
• Negative Sentiment: Analyst commentary also points to higher expenses and weaker outpatient surgery volume as potential drags on second-quarter results, which may be weighing on the stock. Will Higher Expenses Impact HCA Healthcare’s Q2 Earnings?

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.